ArticleFunctional & integrative genomics2026
Cytoplasmic SNHG1 is enriched in prostate cancer stress granules.
Article in Functional & integrative genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
SNHG1 is a long non-coding RNA (lncRNA) with a variably reported subcellular localization to either the nucleus or cytoplasm. Its primary activity has been suggested as a competitive endogenous RNA (ceRNA), however, SNHG1 has also been shown to bind directly to proteins, including G3BP1, G3BP2, and DDX3X, all of which are associated with stress granules. Here we analyze the subcellular localization of SNHG1 in prostate cancer cells and determined the association with stress granules. Quantitation of individual SNHG1 transcripts by single molecule (sm)RNA-FISH showed that C4-2B and PC3 cells contained a median of 13 and 7.5 transcripts per cell, respectively. SNHG1 was predominantly nuclear, with most transcripts found in the nucleus of C4-2B and PC3 cells. The number of transcripts in individual cells varied greatly, from 0 to 36, indicating SNHG1 is expressed at low levels. We induced stress granule formation using thapsigargin to determine whether SNHG1 was localized in stress granules. Stress granules were visualized by G3BP1 immunofluorescence concurrently with SNHG1 RNA by smRNA-FISH. We found enrichment of SNHG1 in C4-2B and PC3 stress granules. Thapsigargin treatment also induced a shift in SNHG1 distribution to favor cytoplasmic localization. In C4-2B cells, the change was small, however, in PC3 cells, SNHG1 localization flipped to become predominantly cytoplasmic. These data show that SNHG1 is predominantly a nuclear RNA expressed at low levels, and stress induction induces an association with stress granules and a cell-dependent shift to the cytoplasm.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.